Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) PT at $70.83

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) has earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have updated their coverage on the stock […]

Leave a Reply

Your email address will not be published.

Previous post OPENLANE’s (KAR) Outperform Rating Reiterated at Barrington Research
Next post OPENLANE (KAR) Expected to Announce Earnings on Wednesday